Lynch & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.95M | Sell |
|
|||||
|
2025
Q2 | $1.99M | Sell |
|
|||||
|
2025
Q1 | $2.25M | Sell |
|
|||||
|
2024
Q4 | $2.38M | Sell |
|
|||||
|
2024
Q3 | $2.71M | Sell |
|
|||||
|
2024
Q2 | $2.72M | Buy |
|
|||||
|
2024
Q1 | $2.5M | Sell |
|
|||||
|
2023
Q4 | $3.61M | Sell |
|
|||||
|
2023
Q3 | $5.17M | Sell |
|
|||||
|
2023
Q2 | $7.1M | Sell |
|
|||||
|
2023
Q1 | $8.1M | Sell |
|
|||||
|
2022
Q4 | $10.5M | Buy |
|
|||||
|
2022
Q3 | $8.99M | Sell |
|
|||||
|
2022
Q2 | $10.9M | Sell |
|
|||||
|
2022
Q1 | $10.8M | Sell |
|
|||||
|
2021
Q4 | $12.7M | Buy |
|
|||||
|
2021
Q3 | $9.19M | Buy |
|
|||||
|
2021
Q2 | $8.27M | Buy |
|
|||||
|
2021
Q1 | $7.57M | Buy |
|
|||||
|
2020
Q4 | $7.53M | Sell |
|
|||||
|
2020
Q3 | $7.32M | Buy |
|
|||||
|
2020
Q2 | $6.5M | Sell |
|
|||||
|
2020
Q1 | $6.62M | Buy |
|
|||||
|
2019
Q4 | $7.83M | Sell |
|
|||||
|
2019
Q3 | $7.3M | Buy |
|
|||||
|
2019
Q2 | $8.77M | Buy |
|
|||||
|
2019
Q1 | $8.52M | Buy |
|
|||||
|
2018
Q4 | $8.67M | Sell |
|
|||||
|
2018
Q3 | $8.76M | Sell |
|
|||||
|
2018
Q2 | $7.36M | Buy |
|
|||||
|
2018
Q1 | $6.79M | Buy |
|
|||||
|
2017
Q4 | $6.71M | Buy |
|
|||||
|
2017
Q3 | $6.5M | Buy |
|
|||||
|
2017
Q2 | $5.87M | Buy |
|
|||||
|
2017
Q1 | $5.85M | Buy |
|
|||||
|
2016
Q4 | $5.44M | Buy |
|
|||||
|
2016
Q3 | $5.64M | Buy |
|
|||||
|
2016
Q2 | $5.81M | Buy |
|
|||||
|
2016
Q1 | $4.52M | Sell |
|
|||||
|
2015
Q4 | $4.97M | Sell |
|
|||||
|
2015
Q3 | $4.86M | Buy |
|
|||||
|
2015
Q2 | $5.09M | Buy |
|
|||||
|
2015
Q1 | $5.22M | Buy |
|
|||||
|
2014
Q4 | $4.41M | Buy |
|
|||||
|
2014
Q3 | $4.04M | Sell |
|
|||||
|
2014
Q2 | $4.14M | Sell |
|
|||||
|
2014
Q1 | $4.54M | Buy |
|
|||||
|
2013
Q4 | $4.23M | Buy |
|
|||||
|
2013
Q3 | $3.8M | Buy |
|
|||||
|
2013
Q2 | $3.64M | Buy |
|